{"issuance_frequency":"","notes_translated":{"fr":"Une entreprise pharmaceutique titulaire d'une licence obligatoire en vertu du Régime canadien d'accès aux médicaments doit verser des redevances au titulaire du brevet. L'entreprise doit effectuer des versements au cours d'une période précise et selon la formule prévue.","en":"A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"9476a49c-d9e1-4952-acd7-af0ac9992f16","metadata_created":"2020-09-17T19:30:34.463359","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-17T19:30:34.463366","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-09-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Régime canadien d'accès aux médicaments","entreprise pharmaceutique titulaire d'une licence obligatoire","titulaire du brevet","versement des redevances"],"en":["Canada's Access to Medicines Regime","company that holds a compulsory licence","patent holder","Royalty payments."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Versement des redevances : Régime canadien d'accès aux médicaments","en":"Royalty payments and Canada's Access to Medicines Regime"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"9476a49c-d9e1-4952-acd7-af0ac9992f16","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2b62eff4-7826-4afc-9e28-82576c8e8707","related_relationship":"","name_translated":{"fr":"Versement des redevances : Régime canadien d'accès aux médicaments","en":"Royalty payments and Canada's Access to Medicines Regime"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Royalty payments and Canada's Access to Medicines Regime","language":["en"],"created":"2020-09-17T19:30:34.629407","url":"https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/companies/application-process/royalty-payments.html","last_modified":null,"position":0,"revision_id":"e05eefbd-e797-49f8-8d96-9f4236a8681f","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9476a49c-d9e1-4952-acd7-af0ac9992f16","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"767c589c-c34f-4c88-afc3-433030a332c2","related_relationship":"","name_translated":{"fr":"Versement des redevances : Régime canadien d'accès aux médicaments","en":"Royalty payments and Canada's Access to Medicines Regime"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Royalty payments and Canada's Access to Medicines Regime","language":["fr"],"created":"2020-09-17T19:30:34.629412","url":"https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/entreprises/processus-demande/versement-redevances.html","last_modified":null,"position":1,"revision_id":"e05eefbd-e797-49f8-8d96-9f4236a8681f","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2017-04-28 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"9476a49c-d9e1-4952-acd7-af0ac9992f16","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula. ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Royalty payments and Canada's Access to Medicines Regime","revision_id":"e05eefbd-e797-49f8-8d96-9f4236a8681f"}